Antibody-drug Conjugate Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	100 Pages	Prof-Research	January, 2025	PROF19449894

Best Price Guarantee
Price	from $3,500
Length	100 Pages
Publisher	Prof-Research
Published Date	January, 2025
SKU	PROF19449894

Antibody-drug Conjugate Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

This report describes the global market size of Antibody-drug Conjugate Therapeutics from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.

For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Antibody-drug Conjugate Therapeutics as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Types Segment:
Gemtuzumab ozogamicin
Brentuximab vedotin
Trastuzumab emtansine
Inotuzumab ozogamicin
Polatuzumab vedotin
Enfortumab vedotin
Trastuzumab deruxtecan
Sacituzumab govitecan
Belantamab mafodotin
Moxetumomab pasudotox
Loncastuximab tesirine

Companies Covered:
ADC Therapeutics SA
Astellas Pharma Inc.
AstraZeneca plc
Daiichi Sankyo Company Ltd.
Genentech Inc.
Gilead Sciences
GlaxoSmithKline
Pfizer
Rakuten Medical Inc.
Seagen
etc.

Please ask for sample pages for full companies list

Base Year: 2025
Historical Data: from 2020 to 2024
Forecast Data: from 2025 to 2030

Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface: 3.1 Research Scope; 3.2 Research Sources; 3.2.1 Data Sources; 3.2.2 Assumptions; 3.3 Research Method
Chapter Four Market Landscape: 4.1 Market Overview; 4.2 Classification/Types; 4.3 Application/End Users
Chapter 5 Market Trend Analysis: 5.1 Introduction; 5.2 Drivers; 5.3 Restraints; 5.4 Opportunities; 5.5 Threats
Chapter 6 Industry Chain Analysis: 6.1 Upstream/Suppliers Analysis; 6.2 Antibody-Drug Conjugate Therapeutics Analysis; 6.2.1 Technology Analysis; 6.2.2 Cost Analysis; 6.2.3 Market Channel Analysis; 6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics: 7.1 Latest News; 7.2 Merger and Acquisition; 7.3 Planned/Future Project; 7.4 Policy Dynamics
Chapter 8 Historical and Forecast Antibody-Drug Conjugate Therapeutics Market in North America (2020-2030): 8.1 Antibody-Drug Conjugate Therapeutics Market Size; 8.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 8.3 Competition by Players/Suppliers; 8.4 Antibody-Drug Conjugate Therapeutics Market Size by Type; 8.5 Key Countries Analysis; 8.5.1 United States; 8.5.2 Canada; 8.5.3 Mexico
Chapter 9 Historical and Forecast Antibody-Drug Conjugate Therapeutics Market in South America (2020-2030): 9.1 Antibody-Drug Conjugate Therapeutics Market Size; 9.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 9.3 Competition by Players/Suppliers; 9.4 Antibody-Drug Conjugate Therapeutics Market Size by Type; 9.5 Key Countries Analysis; 9.5.1 Brazil; 9.5.2 Argentina; 9.5.3 Chile; 9.5.4 Peru
Chapter 10 Historical and Forecast Antibody-Drug Conjugate Therapeutics Market in Asia & Pacific (2020-2030): 10.1 Antibody-Drug Conjugate Therapeutics Market Size; 10.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 10.3 Competition by Players/Suppliers; 10.4 Antibody-Drug Conjugate Therapeutics Market Size by Type; 10.5 Key Countries Analysis; 10.5.1 China; 10.5.2 India; 10.5.3 Japan; 10.5.4 South Korea; 10.5.5 Southest Asia; 10.5.6 Australia
Chapter 11 Historical and Forecast Antibody-Drug Conjugate Therapeutics Market in Europe (2020-2030): 11.1 Antibody-Drug Conjugate Therapeutics Market Size; 11.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 11.3 Competition by Players/Suppliers; 11.4 Antibody-Drug Conjugate Therapeutics Market Size by Type; 11.5 Key Countries Analysis; 11.5.1 Germany; 11.5.2 France; 11.5.3 United Kingdom; 11.5.4 Italy; 11.5.5 Spain; 11.5.6 Belgium; 11.5.7 Netherlands; 11.5.8 Austria; 11.5.9 Poland; 11.5.10 Russia
Chapter 12 Historical and Forecast Antibody-Drug Conjugate Therapeutics Market in MEA (2020-2030): 12.1 Antibody-Drug Conjugate Therapeutics Market Size; 12.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 12.3 Competition by Players/Suppliers; 12.4 Antibody-Drug Conjugate Therapeutics Market Size by Type; 12.5 Key Countries Analysis; 12.5.1 Egypt; 12.5.2 Israel; 12.5.3 South Africa; 12.5.4 Gulf Cooperation Council Countries; 12.5.5 Turkey
Chapter 13 Summary For Global Antibody-Drug Conjugate Therapeutics Market (2020-2025): 13.1 Antibody-Drug Conjugate Therapeutics Market Size; 13.2 Antibody-Drug Conjugate Therapeutics Market by End Use; 13.3 Competition by Players/Suppliers; 13.4 Antibody-Drug Conjugate Therapeutics Market Size by Type
Chapter 14 Global Antibody-Drug Conjugate Therapeutics Market Forecast (2025-2030): 14.1 Antibody-Drug Conjugate Therapeutics Market Size Forecast; 14.2 Antibody-Drug Conjugate Therapeutics Application Forecast; 14.3 Competition by Players/Suppliers; 14.4 Antibody-Drug Conjugate Therapeutics Type Forecast
Chapter 15 Analysis of Global Key Vendors: 15.1 ADC Therapeutics SA; 15.1.1 Company Profile; 15.1.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.1.3 SWOT Analysis of ADC Therapeutics SA; 15.1.4 ADC Therapeutics SA Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.2 Astellas Pharma Inc.; 15.2.1 Company Profile; 15.2.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.2.3 SWOT Analysis of Astellas Pharma Inc.; 15.2.4 Astellas Pharma Inc. Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.3 AstraZeneca plc; 15.3.1 Company Profile; 15.3.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.3.3 SWOT Analysis of AstraZeneca plc; 15.3.4 AstraZeneca plc Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.4 Daiichi Sankyo Company Ltd.; 15.4.1 Company Profile; 15.4.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.4.3 SWOT Analysis of Daiichi Sankyo Company Ltd.; 15.4.4 Daiichi Sankyo Company Ltd. Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.5 Genentech Inc.; 15.5.1 Company Profile; 15.5.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.5.3 SWOT Analysis of Genentech Inc.; 15.5.4 Genentech Inc. Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.6 Gilead Sciences; 15.6.1 Company Profile; 15.6.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.6.3 SWOT Analysis of Gilead Sciences; 15.6.4 Gilead Sciences Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.7 GlaxoSmithKline; 15.7.1 Company Profile; 15.7.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.7.3 SWOT Analysis of GlaxoSmithKline; 15.7.4 GlaxoSmithKline Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.8 Pfizer; 15.8.1 Company Profile; 15.8.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.8.3 SWOT Analysis of Pfizer; 15.8.4 Pfizer Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.9 Rakuten Medical Inc.; 15.9.1 Company Profile; 15.9.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.9.3 SWOT Analysis of Rakuten Medical Inc.; 15.9.4 Rakuten Medical Inc. Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); 15.10 Seagen; 15.10.1 Company Profile; 15.10.2 Main Business and Antibody-drug Conjugate Therapeutics Information; 15.10.3 SWOT Analysis of Seagen; 15.10.4 Seagen Antibody-drug Conjugate Therapeutics Revenue, Gross Margin and Market Share (2020-2025); Please ask for sample pages for full companies list
Tables and Figures: Table Abbreviation and Acronyms; Table Research Scope of Antibody-Drug Conjugate Therapeutics Report; Table Data Sources of Antibody-Drug Conjugate Therapeutics Report; Table Major Assumptions of Antibody-Drug Conjugate Therapeutics Report; Figure Market Size Estimated Method; Figure Major Forecasting Factors; Figure Antibody-Drug Conjugate Therapeutics Picture; Table Antibody-Drug Conjugate Therapeutics Classification; Table Antibody-Drug Conjugate Therapeutics Applications; Table Drivers of Antibody-Drug Conjugate Therapeutics Market; Table Restraints of Antibody-Drug Conjugate Therapeutics Market; Table Opportunities of Antibody-Drug Conjugate Therapeutics Market; Table Threats of Antibody-Drug Conjugate Therapeutics Market; Table Covid-19 Impact For Antibody-Drug Conjugate Therapeutics Market; Table Raw Materials Suppliers; Table Different Production Methods of Antibody-Drug Conjugate Therapeutics; Table Cost Structure Analysis of Antibody-Drug Conjugate Therapeutics; Table Key End Users; Table Latest News of Antibody-Drug Conjugate Therapeutics Market; Table Merger and Acquisition; Table Planned/Future Project of Antibody-Drug Conjugate Therapeutics Market; Table Policy of Antibody-Drug Conjugate Therapeutics Market; Table 2020-2030 North America Antibody-Drug Conjugate Therapeutics Market Size; Figure 2020-2030 North America Antibody-Drug Conjugate Therapeutics Market Size and CAGR; Table 2020-2030 North America Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 North America Antibody-Drug Conjugate Therapeutics Key Players Revenue; Table 2020-2025 North America Antibody-Drug Conjugate Therapeutics Key Players Market Share; Table 2020-2030 North America Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2030 United States Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Canada Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Mexico Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 South America Antibody-Drug Conjugate Therapeutics Market Size; Figure 2020-2030 South America Antibody-Drug Conjugate Therapeutics Market Size and CAGR; Table 2020-2030 South America Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 South America Antibody-Drug Conjugate Therapeutics Key Players Revenue; Table 2020-2025 South America Antibody-Drug Conjugate Therapeutics Key Players Market Share; Table 2020-2030 South America Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2030 Brazil Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Argentina Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Chile Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Peru Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Asia & Pacific Antibody-Drug Conjugate Therapeutics Market Size; Figure 2020-2030 Asia & Pacific Antibody-Drug Conjugate Therapeutics Market Size and CAGR; Table 2020-2030 Asia & Pacific Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 Asia & Pacific Antibody-Drug Conjugate Therapeutics Key Players Revenue; Table 2020-2025 Asia & Pacific Antibody-Drug Conjugate Therapeutics Key Players Market Share; Table 2020-2030 Asia & Pacific Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2030 China Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 India Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Japan Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 South Korea Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Southeast Asia Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Australia Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Europe Antibody-Drug Conjugate Therapeutics Market Size; Figure 2020-2030 Europe Antibody-Drug Conjugate Therapeutics Market Size and CAGR; Table 2020-2030 Europe Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 Europe Antibody-Drug Conjugate Therapeutics Key Players Revenue; Table 2020-2025 Europe Antibody-Drug Conjugate Therapeutics Key Players Market Share; Table 2020-2030 Europe Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2030 Germany Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 France Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 United Kingdom Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Italy Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Spain Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Belgium Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Netherlands Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Austria Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Poland Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Russia Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 MEA Antibody-Drug Conjugate Therapeutics Market Size; Figure 2020-2030 MEA Antibody-Drug Conjugate Therapeutics Market Size and CAGR; Table 2020-2030 MEA Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 MEA Antibody-Drug Conjugate Therapeutics Key Players Revenue; Table 2020-2025 MEA Antibody-Drug Conjugate Therapeutics Key Players Market Share; Table 2020-2030 MEA Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2030 Egypt Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Israel Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 South Africa Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Gulf Cooperation Council Countries Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2030 Turkey Antibody-Drug Conjugate Therapeutics Market Size; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Size by Region; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Size Share by Region; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Share by Application; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Key Vendors Revenue; Figure 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Size and Growth Rate; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Key Vendors Market Share; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2020-2025 Global Antibody-Drug Conjugate Therapeutics Market Share by Type; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Size by Region; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Size Share by Region; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Size by Application; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Share by Application; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Key Vendors Revenue; Figure 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Size and Growth Rate; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Key Vendors Market Share; Table 2025-2030 Global Antibody-Drug Conjugate Therapeutics Market Size by Type; Table 2025-2030 Antibody-Drug Conjugate Therapeutics Global Market Share by Type